
Calidi Biotherapeutics Inc. Featured for Breakthrough Cancer Treatment Platform
Calidi Biotherapeutics Inc. (NYSE American: CLDI) has been highlighted for its innovative genetic medicine platform targeting cancer, offering a novel approach to combat the anticipated rise in global cancer diagnoses.
Read full story


























